Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Tilray Inc buy tbackenh

Tilray Inc
Start price
€11.56
02.09.21 / 60%
Target price
€15.00
02.09.22
Performance (%)
-68.33%
End price
€3.66
02.09.22
Summary
This prediction ended on 02.09.22 with a price of €3.66. Massive losses of -68.33% were the result for the BUY prediction by tbackenh. tbackenh has 60% into this prediction

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w 1m 1y
Tilray Inc -14.105% -14.105% -78.620%
iShares Core DAX® -3.935% -2.628% 10.013%
iShares Nasdaq 100 -3.608% -9.283% 20.668%
iShares Nikkei 225® -4.513% -6.951% 5.241%
iShares S&P 500 -2.607% -4.402% 20.177%

According to tbackenh what are the pros and cons of Tilray Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Some uniques
Future proof or reliable business model
Cons
Higher risks for its business
High valuation

Comments by tbackenh for this prediction

In the thread Tilray Inc diskutieren
Prediction Buy
Perf. (%) -68.33%
Target price 15.000
Change
Ends at 02.09.22

 Tilray (NASDAQ:TLRY), jetzt das größte Cannabisunternehmen der Welt, bietet derzeit herausragende Gewinne für seine Aktionäre. Im letzten Jahr nach dem Kauf der originalen Tilray durch die kanadische Aphria (TSX:APHA) (NASDAQ:APHA), nahm das neu fusionierte Unternehmen den Namen Tilray an. Die Aktie erreichte im März dieses Jahres einige beeindruckende Höchststände und verlor seitdem etwas an Boden. 

tbackenh 
0
Report Share
02.09.21
In the thread Trading Tilray Inc
Prediction Buy
Perf. (%) -68.33%
Target price 15.000
Change
Ends at 02.09.22

Die von tbackenh gewählte maximale Laufzeit wurde überschritten

tbackenh 
0
Report Share
02.09.22

Stopped prediction by tbackenh for Tilray Inc

sell
Tilray Inc

Start price
Target price
Perf. (%)
€193.08
19.09.18
€99.22
24.09.18
-49.06%
24.09.18

Could be worthwhile Investment >10% per year
Some uniques
Future proof or reliable business model
Higher risks for its business
tbackenh 
16.08.19 50%